SCHEMBL2929526

SCHEMBL2929526

O=c1oc2ccccc2cc1-c1ccc(Cl)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.75
RAB9A P51151 5/20 0.75
KDM4E B2RXH2 5/20 0.75
MAOB P27338 5/20 0.75
NPC1 O15118 5/20 0.71
SMN1; SMN2 Q16637 4/20 0.71
GAPDH P04406 2/20 0.71
GAA P10253 2/20 0.71
HPGD P15428 2/20 0.71
NCOA1 Q15788 1/20 0.71
NCOA3 Q9Y6Q9 1/20 0.71
ESR1 P03372 1/20 0.71
ESR2 Q92731 1/20 0.71
L3MBTL1 Q9Y468 1/20 0.71
KMT2A Q03164 2/20 0.69
MIF P14174 2/20 0.66
LMNA P02545 3/20 0.62
MAPT P10636 3/20 0.59
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30356319 0.86 RAB9A (1.00) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL177366 0.86 RAB9A (1.00) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL7124667 0.83 KDM4E (0.75) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL8788473 0.83 RAB9A (0.75) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL2202460 0.83 NCOA1 (1.00) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL14389070 0.83 MAOB (0.75) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL4064740 0.83 ALDH1A1 (1.00) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL30096432 0.83 NCOA1 (1.00) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL29517170 0.82 RAB9A (0.78) ALDH1A1RAB9AKDM4EMAOBNPC1
SCHEMBL27969864 0.81 MIF (0.75) ALDH1A1RAB9AKDM4EMAOBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020130120-A1 CANCER METASTASIS INHIBITOR 学校法人京都薬科大学 2020-06-25 WO disclosed
CN-102757416-B Method for synthesizing 3-arylcoumarin by using N-heterocyclic carbene as catalyst UNIV ZHEJIANG 2014-07-09 CN disclosed
CN-102757416-A Method for synthesizing 3-arylcoumarin by using N-heterocyclic carbene as catalyst UNIV ZHEJIANG 2012-10-31 CN disclosed
EP-2230312-A1 Probe compound for detecting and isolating enzymes and means and methods using the same Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2010-09-22 EP disclosed
EP-2230312-A1 Probe compound for detecting and isolating enzymes and means and methods using the same Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2010-09-22 EP disclosed